Publications by authors named "Rowan Parry"

Claim this Profile
A
Aioli: Standardising Drugs in the FDA Adverse Event Reporting System (FAERS) to RxNorm and Anatomical Therapeutic Chemical (ATC) Codes.
Rowan E Parry, Victor Pera, Katia M C Verhamme, Marcel de Wilde, Erik M van Mulligen

Pharmacoepidemiol Drug Saf· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping between clinical and preclinical terminologies: eTRANSAFE's Rosetta stone approach.
Erik M van Mulligen, Rowan Parry, Johan van der Lei, Jan A Kors

J Biomed Semantics· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardised and Reproducible Phenotyping Using Distributed Analytics and Tools in the Data Analysis and Real World Interrogation Network (DARWIN EU).
Francesco Dernie, George Corby, Abigail Robinson, James Bezer, Nuria Mercade-Besora, Rowan Parry

Pharmacoepidemiol Drug Saf· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System.
Victor Pera, Frauke van Vaerenbergh, Jan A Kors, Erik M van Mulligen, Rowan Parry

Pharmacoepidemiol Drug Saf· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration's adverse event reporting system (FAERS).
Victor Pera, Guy G Brusselle, Sebastian Riemann, Jan A Kors, Erik M Van Mulligen, Rowan Parry

Front Pharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
eTRANSAFE: data science to empower translational safety assessment.
Ferran Sanz, François Pognan, Thomas Steger-Hartmann, Carlos Díaz, Shoji Asakura, Rowan Parry

Nat Rev Drug Discov· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis